Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.11.450111106218.9550
Domestic EquitiesMax Healthcare Institute Ltd.6.77408999911.2139
Domestic EquitiesCipla Ltd.6.14366542110.1703
Domestic EquitiesDivi's Laboratories Ltd.5.5076138249.1176
Domestic EquitiesApollo Hospitals Enterprise Ltd.5.2753116478.7329
Domestic EquitiesDr. Reddy's Laboratories Ltd.5.1869675958.5866
Domestic EquitiesTorrent Pharmaceuticals Ltd.3.0985137085.1294
Domestic EquitiesLupin Ltd.3.0784264175.0961
Domestic EquitiesFortis Healthcare Ltd.2.9413567874.8692
Domestic EquitiesMankind Pharma Ltd.2.2212143233.6770
Domestic EquitiesLaurus Labs Ltd.2.1423405623.5465
Domestic EquitiesGlenmark Pharmaceuticals Ltd.2.1049163283.4846
Domestic EquitiesAurobindo Pharma Ltd.2.0824302453.4473
Domestic EquitiesZydus Lifesciences Ltd.1.7054291112.8232
Domestic EquitiesAlkem Laboratories Ltd.1.471948432.4366
Domestic EquitiesBiocon Ltd.1.4632618862.4222
Domestic EquitiesIPCA Laboratories Ltd.1.4377161482.3801
Domestic EquitiesGland Pharma Ltd.1.070285801.7716
Domestic EquitiesNarayana Hrudayalaya ltd.0.957682771.5852
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Ltd.0.936349011.5500
Domestic EquitiesSyngene International Ltd.0.9041209621.4967
Domestic EquitiesAjanta Pharma Ltd.0.840850591.3919
Domestic EquitiesPiramal Pharma Ltd.0.8217690381.3603
Domestic EquitiesGlobal Health Ltd.0.738593241.2226
Domestic EquitiesCohance Lifesciences Ltd.0.7107117841.1766
Total 71.0646 117.6434
Cash & Cash Equivalents and Net AssetsClearing Corporation of India Ltd.0.2536 0.4199
Cash & Cash Equivalents and Net AssetsAccrued Interest0.0000 0.0001
Cash & Cash Equivalents and Net AssetsNet Receivables/(Payables)-0.0199 -0.0329
Total 0.2338 0.3871
Overseas EquitiesELI LILLY & CO4.978812728.2421
Overseas EquitiesJOHNSON & JOHNSON3.310938005.4810
Overseas EquitiesABBVIE INC2.791227924.6206
Overseas EquitiesABBOTT LABORATORIES1.825427353.0218
Overseas EquitiesNOVARTIS AG1.803429982.9855
Overseas EquitiesMERCK & CO.INC1.639439682.7140
Overseas EquitiesTHERMO FISHER SCIENTIFIC INC1.47185952.4364
Overseas EquitiesINTUITIVE SURGICAL INC1.43515642.3757
Overseas EquitiesAMGEN INC1.32048462.1858
Overseas EquitiesNovo Nordisk A/S1.246550072.0635
Overseas EquitiesGILEAD SCIENCES INC1.166419641.9309
Overseas EquitiesSTRYKER CORP1.12375411.8602
Overseas EquitiesDANAHER CORP1.062610191.7590
Overseas EquitiesVERTEX PHARMACEUTICALS INC0.97624041.6160
Overseas EquitiesMEDTRONIC PLC0.965120221.5976
Overseas EquitiesRegeneron Pharmaceuticals Inc0.48461680.8023
Overseas EquitiesBECTON DICKINSON AND CO0.42244480.6992
Overseas EquitiesIQVIA HOLDINGS INC0.27232770.4508
Overseas EquitiesAGILENT TECHNOLOGIES INC0.27144470.4493
Overseas EquitiesILLUMINA INC0.13422470.2221
Total 28.7016 47.5138
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.